On the pathogenesis and therapy of dementia of the Alzheimer type: Some neuropathological biochemical genetic and pharmacotherapeutic considerations
Identifieur interne : 004E27 ( Main/Exploration ); précédent : 004E26; suivant : 004E28On the pathogenesis and therapy of dementia of the Alzheimer type: Some neuropathological biochemical genetic and pharmacotherapeutic considerations
Auteurs : Rosita F. De Estable-Puig [Canada] ; Juan F. Estable-Puig [Canada] ; M. R. Ven Murthy [Canada] ; Simone Radouco-Thomas [Canada] ; Swarn Chawla [Canada] ; Monelly Radouco-Thomas [Canada] ; Corneille Radouco-Thomas [Canada]Source :
- Progress in Neuropsychopharmacology & Biological Psychiatry [ 0278-5846 ] ; 1986.
Abstract
De Estable-Puig, Rosita F., Juan F. Estable-Puig, M. R. ven Murthy, Simone Radouco-Thomas, Swarn Chawla, Monelly Radouco-Thomas and Corneille Radouco-Thomas: On the pathogenesis and therapy of dementia of the Alzheimer types Some neuropathological, biochemical, genetic and pharmacotherapeutic considerations. Prog. Neuro-Psychopharmacol. & Biol. Psychiat. 1986 10 (3–5): 355–390. 1.1. The extensive literature on dementia of Alzheimer type (DAT) testifies to the enormous progress achieved in the clinical and biochemical delineation of this disease. Newly developed laboratory and imaging techniques are also being applied to the diagnosis of DAT. Nevertheless, unequivoval diagnosis still relies primarily on morphological data from biopsy or autopsy.2.2. An overview is presented of major morphological changes occurring at different levels of organization in the central nervous system (CNS) in DAT.3.3. Currently formulated etiopathogenic hypotheses of DAT are reviewed and discussed in the context of morphological alterations.4.4. Some of the recombinant DNA methods, that are currently available for gene analysis, are described. Some approaches for studying Alzheimer specific genes using the above methods have been suggested.5.5. Finally, a critical overview of the current pharmacotherapeutic armamentarium used in DAT and senile dementia is presented. The efficacy, side effects, and the main mechanisms of action of the two categories of drug therapy —supposed etiopathogenic and symptomatic— are presented.
Url:
DOI: 10.1016/0278-5846(86)90012-6
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001E75
- to stream Istex, to step Curation: 001E75
- to stream Istex, to step Checkpoint: 002420
- to stream Main, to step Merge: 005833
- to stream Main, to step Curation: 004E27
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>On the pathogenesis and therapy of dementia of the Alzheimer type: Some neuropathological biochemical genetic and pharmacotherapeutic considerations</title><author><name sortKey="De Estable Puig, Rosita F" sort="De Estable Puig, Rosita F" uniqKey="De Estable Puig R" first="Rosita F." last="De Estable-Puig">Rosita F. De Estable-Puig</name></author><author><name sortKey="Estable Puig, Juan F" sort="Estable Puig, Juan F" uniqKey="Estable Puig J" first="Juan F." last="Estable-Puig">Juan F. Estable-Puig</name></author><author><name sortKey="Ven Murthy, M R" sort="Ven Murthy, M R" uniqKey="Ven Murthy M" first="M. R." last="Ven Murthy">M. R. Ven Murthy</name></author><author><name sortKey="Radouco Thomas, Simone" sort="Radouco Thomas, Simone" uniqKey="Radouco Thomas S" first="Simone" last="Radouco-Thomas">Simone Radouco-Thomas</name></author><author><name sortKey="Chawla, Swarn" sort="Chawla, Swarn" uniqKey="Chawla S" first="Swarn" last="Chawla">Swarn Chawla</name></author><author><name sortKey="Radouco Thomas, Monelly" sort="Radouco Thomas, Monelly" uniqKey="Radouco Thomas M" first="Monelly" last="Radouco-Thomas">Monelly Radouco-Thomas</name></author><author><name sortKey="Radouco Thomas, Corneille" sort="Radouco Thomas, Corneille" uniqKey="Radouco Thomas C" first="Corneille" last="Radouco-Thomas">Corneille Radouco-Thomas</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:82A08F200084893EA11892351075523355603293</idno><date when="1986" year="1986">1986</date><idno type="doi">10.1016/0278-5846(86)90012-6</idno><idno type="url">https://api-v5.istex.fr/document/82A08F200084893EA11892351075523355603293/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001E75</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001E75</idno><idno type="wicri:Area/Istex/Curation">001E75</idno><idno type="wicri:Area/Istex/Checkpoint">002420</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">002420</idno><idno type="wicri:doubleKey">0278-5846:1986:De Estable Puig R:on:the:pathogenesis</idno><idno type="wicri:Area/Main/Merge">005833</idno><idno type="wicri:Area/Main/Curation">004E27</idno><idno type="wicri:Area/Main/Exploration">004E27</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">On the pathogenesis and therapy of dementia of the Alzheimer type: Some neuropathological biochemical genetic and pharmacotherapeutic considerations</title><author><name sortKey="De Estable Puig, Rosita F" sort="De Estable Puig, Rosita F" uniqKey="De Estable Puig R" first="Rosita F." last="De Estable-Puig">Rosita F. De Estable-Puig</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Départements de Pathologie Biochimie et Pharmacologie et Toxicologie, Faculté de Médecine, Université Laval, Québec</wicri:regionArea><wicri:noRegion>Québec</wicri:noRegion></affiliation></author><author><name sortKey="Estable Puig, Juan F" sort="Estable Puig, Juan F" uniqKey="Estable Puig J" first="Juan F." last="Estable-Puig">Juan F. Estable-Puig</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Départements de Pathologie Biochimie et Pharmacologie et Toxicologie, Faculté de Médecine, Université Laval, Québec</wicri:regionArea><wicri:noRegion>Québec</wicri:noRegion></affiliation></author><author><name sortKey="Ven Murthy, M R" sort="Ven Murthy, M R" uniqKey="Ven Murthy M" first="M. R." last="Ven Murthy">M. R. Ven Murthy</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Départements de Pathologie Biochimie et Pharmacologie et Toxicologie, Faculté de Médecine, Université Laval, Québec</wicri:regionArea><wicri:noRegion>Québec</wicri:noRegion></affiliation></author><author><name sortKey="Radouco Thomas, Simone" sort="Radouco Thomas, Simone" uniqKey="Radouco Thomas S" first="Simone" last="Radouco-Thomas">Simone Radouco-Thomas</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Départements de Pathologie Biochimie et Pharmacologie et Toxicologie, Faculté de Médecine, Université Laval, Québec</wicri:regionArea><wicri:noRegion>Québec</wicri:noRegion></affiliation></author><author><name sortKey="Chawla, Swarn" sort="Chawla, Swarn" uniqKey="Chawla S" first="Swarn" last="Chawla">Swarn Chawla</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Départements de Pathologie Biochimie et Pharmacologie et Toxicologie, Faculté de Médecine, Université Laval, Québec</wicri:regionArea><wicri:noRegion>Québec</wicri:noRegion></affiliation></author><author><name sortKey="Radouco Thomas, Monelly" sort="Radouco Thomas, Monelly" uniqKey="Radouco Thomas M" first="Monelly" last="Radouco-Thomas">Monelly Radouco-Thomas</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Départements de Pathologie Biochimie et Pharmacologie et Toxicologie, Faculté de Médecine, Université Laval, Québec</wicri:regionArea><wicri:noRegion>Québec</wicri:noRegion></affiliation></author><author><name sortKey="Radouco Thomas, Corneille" sort="Radouco Thomas, Corneille" uniqKey="Radouco Thomas C" first="Corneille" last="Radouco-Thomas">Corneille Radouco-Thomas</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Départements de Pathologie Biochimie et Pharmacologie et Toxicologie, Faculté de Médecine, Université Laval, Québec</wicri:regionArea><wicri:noRegion>Québec</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Progress in Neuropsychopharmacology & Biological Psychiatry</title><title level="j" type="abbrev">PNP</title><idno type="ISSN">0278-5846</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1986">1986</date><biblScope unit="volume">10</biblScope><biblScope unit="issue">3–5</biblScope><biblScope unit="page" from="355">355</biblScope><biblScope unit="page" to="390">390</biblScope></imprint><idno type="ISSN">0278-5846</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0278-5846</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">De Estable-Puig, Rosita F., Juan F. Estable-Puig, M. R. ven Murthy, Simone Radouco-Thomas, Swarn Chawla, Monelly Radouco-Thomas and Corneille Radouco-Thomas: On the pathogenesis and therapy of dementia of the Alzheimer types Some neuropathological, biochemical, genetic and pharmacotherapeutic considerations. Prog. Neuro-Psychopharmacol. & Biol. Psychiat. 1986 10 (3–5): 355–390. 1.1. The extensive literature on dementia of Alzheimer type (DAT) testifies to the enormous progress achieved in the clinical and biochemical delineation of this disease. Newly developed laboratory and imaging techniques are also being applied to the diagnosis of DAT. Nevertheless, unequivoval diagnosis still relies primarily on morphological data from biopsy or autopsy.2.2. An overview is presented of major morphological changes occurring at different levels of organization in the central nervous system (CNS) in DAT.3.3. Currently formulated etiopathogenic hypotheses of DAT are reviewed and discussed in the context of morphological alterations.4.4. Some of the recombinant DNA methods, that are currently available for gene analysis, are described. Some approaches for studying Alzheimer specific genes using the above methods have been suggested.5.5. Finally, a critical overview of the current pharmacotherapeutic armamentarium used in DAT and senile dementia is presented. The efficacy, side effects, and the main mechanisms of action of the two categories of drug therapy —supposed etiopathogenic and symptomatic— are presented.</div></front></TEI><affiliations><list><country><li>Canada</li></country></list><tree><country name="Canada"><noRegion><name sortKey="De Estable Puig, Rosita F" sort="De Estable Puig, Rosita F" uniqKey="De Estable Puig R" first="Rosita F." last="De Estable-Puig">Rosita F. De Estable-Puig</name></noRegion><name sortKey="Chawla, Swarn" sort="Chawla, Swarn" uniqKey="Chawla S" first="Swarn" last="Chawla">Swarn Chawla</name><name sortKey="Estable Puig, Juan F" sort="Estable Puig, Juan F" uniqKey="Estable Puig J" first="Juan F." last="Estable-Puig">Juan F. Estable-Puig</name><name sortKey="Radouco Thomas, Corneille" sort="Radouco Thomas, Corneille" uniqKey="Radouco Thomas C" first="Corneille" last="Radouco-Thomas">Corneille Radouco-Thomas</name><name sortKey="Radouco Thomas, Monelly" sort="Radouco Thomas, Monelly" uniqKey="Radouco Thomas M" first="Monelly" last="Radouco-Thomas">Monelly Radouco-Thomas</name><name sortKey="Radouco Thomas, Simone" sort="Radouco Thomas, Simone" uniqKey="Radouco Thomas S" first="Simone" last="Radouco-Thomas">Simone Radouco-Thomas</name><name sortKey="Ven Murthy, M R" sort="Ven Murthy, M R" uniqKey="Ven Murthy M" first="M. R." last="Ven Murthy">M. R. Ven Murthy</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004E27 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004E27 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:82A08F200084893EA11892351075523355603293
|texte= On the pathogenesis and therapy of dementia of the Alzheimer type: Some neuropathological biochemical genetic and pharmacotherapeutic considerations
}}
| This area was generated with Dilib version V0.6.29. |  |